By creating medicines to control the expression of genes that have gone awry in disease, we aim to make a profound difference in the lives of patients and their families.
At the heart of all our efforts at Syros is our dedication to advancing medicines that provide a profound and durable benefit for patients with difficult-to-treat diseases.
We currently have two programs in clinical trials in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced solid tumors, including triple negative breast, small cell lung and ovarian cancers. We have additional programs in earlier stages of research for cancer, autoimmune diseases and genetic disorders.
Interested in participating in a clinical trial?